Seasonal Affective Disorder: Research on Causes, Light Therapy, and Treatment

Seasonal affective disorder is a form of recurrent depression that follows a seasonal pattern, most commonly emerging in the fall and winter months and remitting in spring, though a less common summer pattern also exists. Research estimates that approximately 5 percent of Americans experience SAD, with many more experiencing subsyndromal seasonal mood changes that do not meet full diagnostic criteria but cause meaningful distress. Research on the biological mechanisms of SAD and on the effectiveness of different treatment approaches has advanced substantially, with light therapy emerging as a well-supported first-line intervention. The seasonal pattern of SAD reflects underlying biological mechanisms related to light exposure, circadian rhythms, and neurotransmitter systems. Research on SAD pathophysiology has examined several candidate mechanisms. The phase shift hypothesis proposes that the circadian clock in SAD patients becomes misaligned with the external environment, with biological rhythms shifted later relative to the sleep-wake cycle, producing symptoms when light exposure is insufficient to maintain normal alignment. Research on circadian rhythm parameters in SAD patients finds evidence of phase delays in biological markers including body temperature rhythms and melatonin secretion compared to healthy controls. Serotonin dysregulation is another proposed mechanism. Research finds differences in serotonin transporter function between SAD patients and healthy controls, with transporter levels and binding characteristics varying with season in ways that may affect serotonin availability. The observation that bright light exposure affects serotonin synthesis and that serotonin reuptake inhibitors are effective in SAD treatment provides converging evidence for a serotonin mechanism. However, the specific neural pathways through which these mechanisms produce the depressive symptoms of SAD remain incompletely understood. Light therapy, which involves daily exposure to bright artificial light of specified intensity, typically 10,000 lux for 20 to 30 minutes in the morning, is the best-supported first-line treatment for winter SAD. Research including randomized controlled trials has found that light therapy produces significant reductions in SAD symptom severity, with effects appearing within days to two weeks of starting treatment. Light therapy is typically continued through the winter season, with symptoms returning if it is discontinued. The therapeutic mechanism is thought to involve correcting circadian phase shifts and potentially affecting serotonin through light-induced serotonin synthesis. Meta-analyses of light therapy for SAD find consistent positive effects, with effect sizes comparable to those for antidepressant medication in the published literature. Research on head-to-head comparisons of light therapy and medication finds comparable efficacy, with some evidence that the combination produces better outcomes than either treatment alone. Light therapy has the advantage of rapid onset, lack of systemic side effects for most users, and acceptability to patients who prefer non-pharmacological approaches. Side effects of light therapy are mild and temporary for most users, including headache and eye strain, and bright light should be used cautiously in individuals with certain eye conditions or bipolar disorder. Antidepressant medications, particularly bupropion, have evidence supporting their efficacy in SAD and are recommended when light therapy is ineffective or not tolerable. Research on bupropion as prophylaxis for SAD, started in the fall before symptoms typically emerge, finds reduced rates of SAD episodes compared to placebo. Serotonin reuptake inhibitors are also commonly used and have evidence of effectiveness in SAD, similar to their efficacy in non-seasonal depression. Behavioral and lifestyle interventions including exercise, maintaining regular sleep-wake schedules, increasing time outdoors during daylight hours, and social engagement are recommended as adjuncts to primary treatments. Research on exercise and mood in SAD finds that regular physical activity improves mood and may have specific benefits for seasonal depression beyond those of exercise in non-seasonal depression, possibly through effects on circadian rhythms and monoamine neurotransmitter systems. Cognitive-behavioral therapy adapted for SAD has been studied and found effective in randomized trials. Research comparing CBT for SAD to light therapy finds that CBT produces comparable acute treatment effects and may produce better maintenance of improvement in the following winter season compared to light therapy, which requires continued use. This durability advantage for CBT may reflect the development of skills that help patients cope with and manage seasonal mood changes over subsequent winters.